regeneron pharmaceuticals
(REGN:NASDAQ GS)

Executive Profile*

Background*

Dr. Marc Tessier-Lavigne, Ph.D., serves as the Chief Scientific Officer and Executive Vice President of Research of Genentech, Inc. Dr. Tessier-Lavigne has been the President of The Rockefeller University since 2011, where he also serves as a professor and head of the laboratory of brain development and repair. Dr. Tessier-Lavigne is a Co-founder of Renovis Inc. He served as an Executive Vice President of Research Drug Discovery of Genentech Inc. since June 2008 and ... also its Chief Scientific Officer of South San Francisco since April 2009. Dr. Tessier-Lavigne served as Senior Vice President of Research Drug Discovery at Genentech Inc. from September 2003 to June 2008. Dr. Tessier-Lavigne served as a Consultant for a variety of biotechnology companies and also served as a Scientific Advisor to Exelixis Inc. Dr. Tessier-Lavigne joined Genentech Inc., from Stanford University, where he was the Susan B. Ford Professor in the School of Humanities and Sciences, as well as a Professor of Biological Sciences and a professor of Neurology and Neurological Sciences. He was also an investigator with the Howard Hughes Medical Institute, which appoints leading biomedical scientists to prestigious research positions based on their potential to make significant contributions to science. He has been the Director of Pfizer Inc. since December 12, 2011. He has been a Director of Regeneron Pharmaceuticals, Inc. since November 18, 2011. He serves as a Director of AMDeC, LLC and of AMDeC Foundation, Inc. He has been a Director of Agios Pharmaceuticals, Inc. since September 2011. He serves as Member of the Medical and Scientific Review Board at Renovis Inc. A member of numerous scientific editorial advisory boards, including the Board of Reviewing Editors for Science magazine, Dr. Tessier-Lavigne is a frequent lecturer and has authored more than 2000 scientific articles. Dr. Tessier-Lavigne is an elected member of the National Academy of Sciences and its Institute of Medicine the Academy of Medical Sciences (UK), and the American Association for the Advancement of Science. He has earned numerous awards and honors, including being named a Rhodes Scholar, a Fellow of the Royal Society (London), a Fellow of the Royal Society of Canada, and most recently, the recipient of the 2003 Robert Dow Neuroscience Award by the Neurological Sciences Institute in June. He is also the recipient or co-recipient of numerous awards, including the Ameritec Prize for contributions toward a cure for paralysis, the Fondation Ibsen Prize in Neuronal Plasticity, the Viktor Hamburger Award of the International Society for Developmental Neuroscience, the Wakeman Award for regeneration research, the Robert Dow Neuroscience Award, the Reeve-Irvine Research Medal, the Gill Distinguished Award, the W. Alden Spencer Award, and the Memorial Sloan Kettering Medal. Dr. Tessier-Lavigne received a Bachelor's Degree in Physics from McGill University in Montreal, a Bachelor's Degree in Philosophy and Physiology from Oxford University, and a Doctorate in neurophysiology from University College London.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
REGN:US	$250.31 USD	-4.56

COMPETITOR COMPENSATION